Elizabeth L. Barry, PhD
Title(s):
Associate Professor of Epidemiology
Associate Professor of Community and Family Medicine
Department(s):
Epidemiology
Community and Family Medicine
Education:
Dartmouth College CECS, MS 2003
University of Wisconsin-Madison, PhD 1989
Grinnell College, BA 1983
Websites:
https:
http:
Contact Information:
One Medical Center Drive
Rubin Building, Room 857
HB 7927
Lebanon NH 03756
Office: Room 857
Phone: 603-653-9932
Email: elizabeth.l.barry@dartmouth.edu
Professional Interests:
Dr. Barry's current research focuses on the chemoprevention of cancer and the pharmacogenetics of chemopreventative agents. She is especially interested in the role and mechanism of action of anti-inflammatory drugs (such as aspirin) and nutritional supplements (such as calcium, vitamin D and folate) as chemopreventative agents for cancer. Using data from clinical trials, Dr. Barry is currently investigating how genetic polymorphisms may modify the effectiveness of some of these drugs in the prevention of colorectal adenomas. In addition to her interest in cancer, Dr. Barry has a long-standing interest in calcium and vitamin D regulation and their role in bone health and disease (osteoporosis).
Courses Taught:
Medical Pharmacology (Calcium and Bone Pharmacology)
Selected Publications: |
|
Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial. Vitamin D as Cancer Therapy?: Insights From 2 New Trials. Effects of supplemental calcium and vitamin D on tight-junction proteins and mucin-12 expression in the normal rectal mucosa of colorectal adenoma patients. No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial. Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal-appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial. NSAIDs and Colorectal Cancer Phenotypes: What Now? Effects of Supplemental Calcium and Vitamin D on Expression of Toll-Like Receptors and Phospho-IKKα/β in the Normal Rectal Mucosa of Colorectal Adenoma Patients. Body mass index, calcium supplementation and risk of colorectal adenomas. Novel Common Genetic Susceptibility Loci for Colorectal Cancer. |
|
